Drug Utilization Study for Pirinase Hayfever Relief

• Status: Completed
• Trial end date: 2018-03-31
• Target enrollment: 0
• Participant gender: All

Summary

The purpose is to obtain real-world information on how consumers are complying with the product labelling This study will coincide with the launch of Pirinase Hayfever Relief for Adults 0.05% Nasal Spray in the United Kingdom (UK).

• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: GlaxoSmithKline

Criteria

Inclusion Criteria:

• Participants will be required to review, and electronically sign a Participation Agreement prior to completing the online survey.

• Participants of any age may participate.

• Participants who have purchased and used Pirinase Hayfever Relief for Adults 0.05% Nasal Spray for at least 7 days and are willing to participate in the online survey.

• Participants of either gender may participate

Exclusion Criteria:

• Anyone who is directly involved with medicines such as doctors, nurses, and pharmacists.

• Participants who decline participation in the online survey